Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Heart Failure × Trastuzumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 520 Stomach Neoplasms 57 Neoplasm Metastasis 47 Neoplasms 35 HER2-positive Breast Cancer 29 Breast Neoplasms, Male 26 Colorectal Neoplasms 23 Brain Neoplasms 20 Esophageal Neoplasms 19 Carcinoma, Non-Small-Cell Lung 17 Inflammatory Breast Neoplasms 15 Triple Negative Breast Neoplasms 11 Pancreatic Neoplasms 10 Endometrial Neoplasms 9 Colonic Neoplasms 9 Rectal Neoplasms 8 Ovarian Neoplasms 8 Adenocarcinoma Of Esophagus 7 Adenocarcinoma 7 Urinary Bladder Neoplasms 6 Sarcoma 6 Salivary Gland Neoplasms 6 Prostatic Neoplasms 6 Pathologic Complete Response 6 Lung Neoplasms 6 Gallbladder Neoplasms 6 Cardiotoxicity 6 Biliary Tract Neoplasms 6 Squamous Cell Carcinoma of Head and Neck 5 Breast Diseases 5

Interventions

Echocardiography 4 Standard of Care 3 Exercise 3 Electrocardiography 3 sacubitril and valsartan sodium hydrate drug combination 2 Surveys and Questionnaires 2 Spironolactone 2 Rituximab 2 Nutrition Assessment 2 Lenalidomide 2 Ivabradine 2 Control Groups 2 Carvedilol 2 Blood Specimen Collection 2 Atorvastatin 2 Adrenergic beta-Antagonists 2 ziprasidone 1 pertuzumab 1 pegfilgrastim 1 obinutuzumab 1 nicotinamide-beta-riboside 1 empagliflozin 1 dapagliflozin 1 candesartan 1 acalabrutinib 1 Zolpidem 1 Watchful Waiting 1 Warfarin 1 Vincristine 1 Vecuronium Bromide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04680442 2025-04-06

SCHOLAR-2

Population Health Research Institute

Phase 2 Recruiting

Breast Neoplasms, Heart Failure

Data powered by HemOnc (CC BY 4.0) Colophon ⚡